Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 571-575

  Lee, Su Jeong ^a   Lee, Sin Yeob ^b   Jeon, Hyo Sung ^c   Park, Sun Ha ^c   Jang, Jin Sung ^a   Lee, Ga Young ^c   Son, Ji Woong ^b   Kim, Chang Ho ^b   Lee, Won Kee ^c   Kam, Sin ^c   Park, Rang Woon ^a   Park, Tae In ^a   Kang, Young Mo ^b   Kim, In San ^a   Jung, Tae Hoon ^b   Park, Jae Yong ^a,b,c  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ALGORITHM; ANGIOGENESIS; ARTICLE; BAYES THEOREM; CANCER RISK; CANCER SUSCEPTIBILITY; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INHERITANCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SMALL CELL CARCINOMA; SOUTH KOREA; TUMOR VASCULARIZATION;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; ODDS RATIO; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20144387124     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0472     Document Type: Article

References (24)

1. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000;18:2309-15.
2. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promise and perils of individuals and population risk estimation? Mutat Res 1998;400:15-24.
3. Folkman J, Watson K, Ingiber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
4. Shi YP, Ferrara N. Oncogenic rats fails to restore an in vivo tumorigenic phenotype in embryo stem cells lacking vascular endothelial growth factor (VEGF). Biochem Biophys Res Commun 1999;254:480-3.
5. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8.
6. Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001;2:667-73.
7. Masuya D, Huang C-H, Liu D, et al. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer 2001;92:2628-38.
8. Fontanini G, Faviana P, Lucchi M, et al. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavorable prognosis in operated small cell lung cancer. Br J Cancer 2002;86:558-63.
9. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996;93:1493-5.
10. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple proteins forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-54.
11. Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC. Identification of polymorphisms within the vascular endothelial growth factor (VEFG) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-5.
12. Renner W, Kotschan S, Hoffman C, Obermayer-Pietsch B, Pigler E. A common 936C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial factor plasma levels. J Vasc Res 2000;37:443-8.
13. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003;63:812-6.
14. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumor development in cutaneous malignant melanoma. Genes Immun 2002;3:229-32.
15. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002;13:260-4.
16. Lin CC Wu HC, Tsai FJ, Chen HY, Chen WC. Vascular endothelial growth factor gene -460C/T polymorphism is a biomarker for prostate cancer. Urology 2003;62:374-7.
17. Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003;106: 468-71.
18. Jeon H-S, Kim KM, Park SH, et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003;24: 1677-81.
19. Lee C-T, Rang KH, Koh Y, et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer 2000;30:15-22.
20. Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-89.
21. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1630-5.
22. Sakao S, Tatsumi K, Hashimoto T, et al. Vascular endothelial growth factor and the risk of smoking-related COPD. Chest 2003; 124:323-7.
23. Balasubramanian SP, Brown NJ, Reed MWR. Role of genetic polymorphisms in tumor angiogenesis. Br J Cancer 2002;87:1057-65.
24. McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002;62:3369-72.